EMD-17110

Single-particle
2.9 Å
EMD-17110 Deposition: 11/04/2023
Map released: 30/08/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-17110

CryoEM structure of human rho1 GABAA receptor in complex with GABA and picrotoxin

EMD-17110

Single-particle
2.9 Å
EMD-17110 Deposition: 11/04/2023
Map released: 30/08/2023
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Homo sapiens
Sample: human rho1 GABAA receptor
Fitted models: 8oqa (Avg. Q-score: 0.604)

Deposition Authors: Chen F, Victor T, John C, Rebecca JH, Erik L
Structure and dynamics of differential ligand binding in the human rho-type GABA A receptor.
Cowgill J, Fan C, Haloi N, Tobiasson V , Zhuang Y, Howard RJ, Lindahl E
(2023) Neuron , 111 , 3450 - 3464.e5
PUBMED: 37659407
DOI: doi:10.1016/j.neuron.2023.08.006
ISSN: 0896-6273
ASTM: NERNET
Abstract:
The neurotransmitter γ-aminobutyric acid (GABA) drives critical inhibitory processes in and beyond the nervous system, partly via ionotropic type-A receptors (GABAARs). Pharmacological properties of ρ-type GABAARs are particularly distinctive, yet the structural basis for their specialization remains unclear. Here, we present cryo-EM structures of a lipid-embedded human ρ1 GABAAR, including a partial intracellular domain, under apo, inhibited, and desensitized conditions. An apparent resting state, determined first in the absence of modulators, was recapitulated with the specific inhibitor (1,2,5,6-tetrahydropyridin-4-yl)methylphosphinic acid and blocker picrotoxin and provided a rationale for bicuculline insensitivity. Comparative structures, mutant recordings, and molecular simulations with and without GABA further explained the sensitized but slower activation of ρ1 relative to canonical subtypes. Combining GABA with picrotoxin also captured an apparent uncoupled intermediate state. This work reveals structural mechanisms of gating and modulation with applications to ρ-specific pharmaceutical design and to our biophysical understanding of ligand-gated ion channels.